BioStem Technologies (BSEM) Stock Insights

BSEM price $1.51 +0.03 +1.99%

Ticker
BSEM
Price
$1.51
Change
+0.03 +1.99%
Market cap ?
$28.18M
P/E ?
-0.91
Forward P/E ?
5.39
Dividend yield ?
0.00%
Beta ?
0.27
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
50
Value
58
Quality
42
Growth
50

Stocklytics score rationale: value 58, quality 42, growth 50.

Financials

2016201720182019202020212022202320242025
592297328528101719226303182521639434083968752021668540530182730247482015

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC…

Fair value

BSEM fair value $8.85. Price $1.51. Price is 83% below fair value.

Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 6.59M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 18.67M. Net debt -26.22M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare BSEM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.43—7.17M
2026-08-12-0.52-0.507.90M6.35M
2026-05-14-0.52-0.286.14M5.70M
2026-03-24-0.670.0210.10M55.20M
2025-11-130.030.0210.47M55.20M
2025-08-14-0.030.3249.30M78.20M
2025-05-120.171.2572.50M101.10M
2025-04-140.940.37102.87M86.68M
2024-11-120.320.3682.56M86.68M
2024-08-120.300.1274.49M44.00M
2024-05-140.200.7441.90M12.70M
2024-03-18-0.180.4711.40M11.40M
2023-11-130.03-0.183.60M4.68M
2023-08-02-0.200.021.07M2.20M
2023-05-26-0.05-0.052.00M2.00M
2022-12-31-0.300.02793.09K1.20M
2022-11-15-0.14-0.021.15M1.20M
2022-08-220.02—2.16M—
2022-05-16-0.30—2.78M—
2022-03-31-0.04—1.22M—
2021-09-30-0.05—1.20M—
2021-06-30-0.03—970.51K—
2021-03-31-0.04—952.51K—
2020-12-31-0.07—2.52M—
2020-09-30-0.08—467.62K—
2020-06-30-0.08—238.83K—
2020-03-31-0.04—777.37K—
2019-12-31-0.17—2.63M—
2019-09-30-0.15—722.77K—
2019-06-30-0.23—708.37K—
2019-03-31-0.26—532.78K—
2018-12-31-0.41—541.07K—
2018-09-30-0.20—376.89K—
2018-06-30-0.11—35.31K—
2018-03-31-0.18—63.92K—
2017-12-31-0.05—58.53K—
2017-09-30-0.29—55.28K—
2017-06-30-0.49—84.67K—
2017-03-31-0.08—114.72K—
2016-12-310.44—86.45K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-07SMITH-VAN VURST ANDREWSell250.00K$2.00500.00K
2026-10-07SMITH-VAN VURST ANDREWBuy250.00K$2.00500.00K
2026-10-07Matuszewski JasonSell250.00K$2.00500.00K
2026-10-07Matuszewski JasonBuy250.00K$2.00500.00K
2026-09-17SMITH-VAN VURST ANDREWBuy9.57K——
2026-09-17SMITH-VAN VURST ANDREWSell9.57K——
2026-09-17Matuszewski JasonBuy16.65K——
2026-09-17Matuszewski JasonSell16.65K——
2026-09-15POE BRANDONBuy1.69K——
2026-09-15POE BRANDONSell1.69K——
2026-09-15SMITH-VAN VURST ANDREWBuy7.62K——
2026-09-15SMITH-VAN VURST ANDREWSell7.62K——
2026-09-15Matuszewski JasonBuy8.47K——
2026-09-15Matuszewski JasonSell8.47K——
2026-09-15WARRINGTON KENNETH HOWARD JRBuy1.69K——
2026-09-15WARRINGTON KENNETH HOWARD JRSell1.69K——
2026-09-15FORTUNATO MICHAEL ABuy4.23K——
2026-09-15FORTUNATO MICHAEL ASell4.23K——
2026-09-09HASSETT BARRYBuy500——
2026-09-09HASSETT BARRYSell500——
2026-08-27UNGRODT JODIBuy5.65K——
2026-08-27UNGRODT JODISell5.65K——
2026-08-27Glickman Mark ABuy7.67K——
2026-08-27LESSER HANNAWAY RAYNABuy7.67K——
2026-08-27LESSER HANNAWAY RAYNASell7.67K——
2026-08-27Glickman Mark ASell7.67K——
2026-08-27WARRINGTON KENNETH HOWARD JRBuy5.09K——
2026-08-27WARRINGTON KENNETH HOWARD JRSell5.09K——
2026-08-27SONENREICH STEVEN DBuy7.67K——
2026-08-27SONENREICH STEVEN DSell7.67K——
2026-08-11POE BRANDONBuy10.63K——
2026-08-11POE BRANDONSell10.63K——
2026-08-09FORTUNATO MICHAEL ABuy970——
2026-08-09FORTUNATO MICHAEL ASell970——
2026-08-06SMITH-VAN VURST ANDREWOther0——
2026-08-06SMITH-VAN VURST ANDREWOther2.25M$2.004.50M
2026-08-06SMITH-VAN VURST ANDREWOther23.25K$10.05233.62K
2026-08-06SMITH-VAN VURST ANDREWOther253.30K$5.501.39M
2026-08-06SMITH-VAN VURST ANDREWOther67.02K——
2026-08-06SMITH-VAN VURST ANDREWOther209.09K——
2026-08-06GORRELL KATHERINEOther101.15K$4.60465.27K
2026-08-06GORRELL KATHERINEOther82.46K——
2026-08-06Glickman Mark AOther7.67K——
2026-08-06SONENREICH STEVEN DOther7.67K——
2026-08-06UNGRODT JODIOther0——
2026-08-06UNGRODT JODIOther5.65K——
2026-08-06WARRINGTON KENNETH HOWARD JROther0——
2026-08-06WARRINGTON KENNETH HOWARD JROther7.46K$1.8013.43K
2026-08-06WARRINGTON KENNETH HOWARD JROther5.09K——
2026-08-06HASSETT BARRYOther0——
2026-08-06HASSETT BARRYOther2.43K$14.8936.14K
2026-08-06HASSETT BARRYOther70.48K$5.50387.67K
2026-08-06HASSETT BARRYOther58.18K——
2026-08-06LESSER HANNAWAY RAYNAOther7.67K——
2026-08-06POE BRANDONOther0——
2026-08-06POE BRANDONOther38.81K$6.48251.51K
2026-08-06POE BRANDONOther117.40K$5.50645.71K
2026-08-06POE BRANDONOther96.91K——
2026-08-06Matuszewski JasonOther0——
2026-08-06Matuszewski JasonOther2.25M$2.004.50M
2026-08-06Matuszewski JasonOther40.43K$10.05406.29K
2026-08-06Matuszewski JasonOther440.53K$5.502.42M
2026-08-06Matuszewski JasonOther363.64K——
2026-08-06FORTUNATO MICHAEL AOther0——
2026-08-06FORTUNATO MICHAEL AOther200.00K$1.07214.00K
2026-08-06FORTUNATO MICHAEL AOther100.00K$2.99299.00K
2026-08-06FORTUNATO MICHAEL AOther2.34K$15.1135.36K
2026-08-06FORTUNATO MICHAEL AOther38.55K$5.50212.00K
2026-08-06FORTUNATO MICHAEL AOther31.82K——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

BioStem Technologies (BSEM) Stock Insights

BSEM$1.51+0.03 +1.99%

$28.18M

Market Cap

-0.91

P/E

5.39

Forward P/E

50

Score

Price History